|1.||Adams, Michael: 4 articles (12/2015 - 11/2013)|
|2.||Zimmermann, Stefanie: 3 articles (01/2014 - 11/2013)|
|3.||Hamburger, Matthias: 3 articles (01/2014 - 11/2013)|
|4.||Usuki, Toyonobu: 2 articles (12/2015 - 01/2014)|
|5.||De Mieri, Maria: 2 articles (01/2014 - 11/2013)|
|6.||Kaiser, Marcel: 2 articles (01/2014 - 11/2013)|
|7.||Brun, Reto: 2 articles (11/2013 - 11/2013)|
|8.||Yoo, Eun Sook: 2 articles (05/2004 - 01/2004)|
|9.||Jung, Jee H: 2 articles (05/2004 - 01/2004)|
|10.||Rhee, Man Hee: 2 articles (05/2004 - 01/2004)|
|2.||Body Weight (Weight, Body)
05/25/2004 - "Cynaropicrin potently inhibited the proliferation of leukocyte cancer cell lines, such as U937, Eol-1 and Jurkat T cells, but some other cells such as Chang liver cells and human fibroblast cell lines were not strongly suppressed by cynaropicrin treatment. "
05/25/2004 - "Cytotoxic and pro-apoptotic activities of cynaropicrin, a sesquiterpene lactone, on the viability of leukocyte cancer cell lines."
06/01/2014 - "The leaves of these plants contain high concentrations of sesquiterpene lactones (STLs) among which cynaropicrin is the most represented, and has recently attracted attention because of its therapeutic potential as anti-tumor and anti-photoaging agent. "
05/25/2004 - "Taken together, these results indicate that cynaropicrin may be a potential anticancer agent against some leukocyte cancer cells such as lymphoma or leukemia, through pro-apoptotic activity."
01/23/2004 - "Therefore, our finding is the first demonstration that cynaropicrin may be a potent functional regulator of CD29 and CD98 via interrupting ERK activation which may be linked to cytoskeleton rearrangement, suggesting further application to CD29- and CD98-mediated diseases such as virus-induced chronic inflammation, and invasion, migration, and metastasis of leukocyte cancer cells."
11/01/2013 - "cruzi-infected mice (up to 50 mg/kg/day cynaropicrin) did not suppress parasitemia or protect against mortality induced by the Y and Colombiana strains. "
01/01/2014 - "Sesquiterpene lactones (STLs) are natural products that have potent antitrypanosomal activity in vitro and, in the case of cynaropicrin, also reduce parasitemia in the murine model of trypanosomiasis. "
|5.||African Trypanosomiasis (Nagana)
12/01/2015 - "Cynaropicrin is a guaianolide sesquiterpene lactone, which has potent in vitro and in vivo inhibitory activity against Trypanosoma brucei, the protozoan parasite that causes human African trypanosomiasis (HAT; sleeping sickness). "
11/15/2013 - "In mice cynaropicrin (CYN) potently inhibits the proliferation of Trypanosoma brucei-the causative agent of Human African Trypanosomiasis-by a so far unknown mechanism. "
|2.||Cytochrome P-450 CYP1A1 (CYP1A1)
|3.||Aryl Hydrocarbon Receptors (Aryl Hydrocarbon Receptor)
|4.||Cytochrome P-450 Enzyme System (Cytochrome P450)
|5.||solstitialin A 13-acetate